SlideShare a Scribd company logo
GOOD LABORATORY PRACTICE
 In the early 70’s FDA became aware of cases of poor laboratory
practice all over the United States.
 They discovered a lot fraudulent activities and a lot of poor lab
practices.
 Examples of some of these poor lab practices found were :
1.Equipment not been calibrated to standard form , therefore
giving wrong measurements.
2. Incorrect/inaccurate accounts of the actual lab study.
3. Inadequate test systems.
GLP was first introduced in New Zealand and Denmark in 1972, and later
in the US in 1978 in response to the Industrial Bio Test Labs scandal.
Therapeutic
concept
Target
validation
Lead
finding
Target
selection
Lead
optimization
Preclinical
development
Clinical
development
Regulatory
approval
Product
Discovery
Development
Drug Discovery and Development Process
Registration
3
Good Laboratory Practice (GLP)
 GLP is a formal regulation created by USFDA as these
regulations were proposed on November 19,1976 and designated
as a new part of Chapter 21 of the Code of Federal
Regulations(CFR) as 21 CFR Part 58 in 1979.
organization named OECD(Organization for
 In 1981 an
Economic Cooperation and Development) produced GLP
principles that are international standards.
 GLP in OECD principles is defined as “a quality system
concerned with the organizational process and the conditions
under which non-clinical health and environmental safety studies
are planned, performed, monitored, recorded, archived and
reported”.
4
Why GLP was created?
1) GLPs were initially invoked in a reaction to malpractices in the
laboratories conducting safety experiments of medicines.
2) In the early 1970s,research laboratories in the USA found doing
work in unethical ways ,like:
 Data generation without conduct of the study.
 Falsification of the laboratory work.
 Replacement of dead animals and fabrication of test results etc.
5
Advantages of GLP
 Assures that the data are a true reflection of results obtained from
studies.
 Preclinical safety and residue safety.
 Generation of high quality and reliable test data.
 Mutual acceptance of data
 Increases public confidence.
 Shortens the time-to-market for new products.
Disadvantages of GLP
 More man power is required.
 Expensive process.
 Time consuming process. 6
Objectives of
GLP
1) GLP makes sure that the data submitted are true reflection of the
results obtained from the studies.
2) GLP makes sure that the data is traceable.
3) Promotes international acceptance of tests.
7
GLP
Principles
Testing
facility
organization
and
personnel
Storage
and
retention
of records
and
materials
Reporting
of study
results
Quality
assurance
program
Facilities
Apparatus,
materials
,reagents
Test
systems
Test and
reference
substances
Standard
operating
procedures
Performance
of study 8
How to practice GLP?
A. General provisions
B. Organization and Personnel
C. Facilities
D. Equipment
E. Testing facilities operation
F. Test and control articles
G. Protocol for and the conduct of the study
H. Records and Reports
9
A. General
provisions
1) It prescribes GLP for conducting non-clinical laboratory studies
that support research and marketing permits of products
regulated by FDA.
2) Applicability to studies performed under grants and contracts.
3) Inspection of the testing facility.
10
B. Organization and
Personnel
1) Organization
2) Personnel
3) Testing facility management
4) Study director
5) Quality assurance unit
11
Organization-
Functions
1) Identification of quality activities.
2) Dividing the jobs among the personnel.
of each job and
3) Define the authority and responsibility
relationship of each job with other jobs.
4) Coordinate the work of internal departments and outside agencie1s0.
Personne
l
Each individual engaged in the conduct or supervision of non-
clinical laboratory study shall have:
1) Education
2) Training:
a) General training
b) Specific training
3) Experience or combination
4) Personal sanitation and health precautions 13
Testing facility
management
1) A sufficient number of qualified personnel, appropriate facilities,
equipment and materials are available for conductance of the
study.
2) Maintenance of records of qualifications, training and experience
of personnel and their job description.
3) Appointment of study director.
4) Quality assurance program with designated personnel. 14
Study
Director
A scientist or other professional of appropriate education , training
and experience.
Responsibilities of the study director are:
1) Approval of protocol and study plans including amendments.
2) Technical conduct of the study.
3) Ensure that the QA personnel and study personnel are updated
with the study plan and SOPs.
4) Interpretation, analysis, documentation and reporting of the
results.
5) Also checks that experimental data is accurately recorded and
verified.
6) Sign and date the final report for acceptance of data.
15
Quality Assurance Unit
1) An individual or a group designated by management to assure
that the studies are in compliance with GLPprinciples.
2) Monitors the study to assure management that the facilities ,
equipment, personnel, methods, practices, records and controls
are in conformance with the regulations.
3) Maintain the copies of master schedule sheet, protocol and
SOPs.
4) Access to updated study plans and SOPs.
5) Documented verification of compliance of the study with GLP
principles.
16
Cont.…
5) Inspections to determine the compliance of the study with GLP
principles and three type of inspections are:
a) Study based inspections
b) Process based inspections
c) Facility based inspections
6) Determines any deviation from the approved protocol and report
to SD,PI and management.
7) Prepare statements to be included in the final report containing
dates and types of inspection. 17
C.
Facilities
1) General facilities:
a) Testing system facilities
b) Archive facilities
c) Waste disposal
2) Animal care facilities
18
General
facilities
a) Testing system facilities
Suitable size, construction and location.
Adequate degree of separation of different activities.
Laboratories should be well ventilated, free of dust, drafts and
extreme temperatures.
Minimum 150sq.feet of floor space and minimum 6 linear feet of
usable bench space should be provide for each analyst.
b) Archive facilities- Secure storage and retrieval of study plans,
raw data, final report and specimens to prevent untimely
deterioration.
c) Waste disposal- Appropriate collection, storage and disposal
facilities and decontamination procedures.
19
Animal care
facilities
1) Located away form testing laboratories preferably in a separate building.
2) Contamination risk is reduced by “barrier” system ,as well as by providing
“clean” and “dirty” corridors .
3) Separate areas for animals of different species and studies.
4) Separate areas for diagnosis, treatment and control of laboratory animal
diseases.
5) Lightening should be proper as light intensity and noise level is sufficient.
6) Maintain room temperature, humidity and air changes in animal quarters. 20
D. Equipment
cleaned and
1) Appropriate design and adequate capacity.
2) Equipment shall be adequately inspected,
maintained.
3) Equipment used for generation, measurement or assessment of
data shall be adequately tested, calibrated and standardized.
4) Log books for each equipment should be there.
21
E. Testing Facilities
Operation
1) Standard operating procedures(SOPs)
2) Reagents and solutions
3) Animal care
22
Standard Operating Procedures
(SOPs)
 reference items, apparatus, materials and reagents, record keeping,
reporting, storage and retrieval, test systems and quality assurance
procedures.
 4) Any deviation from SOP should be authorized
by SD and documented in the raw data.
1) Written documents specifying procedures for laboratories
programs.
2) Testing facility should have a written SOP approved by
management.
3) SOPs should be available wherever applicable e.g. test and
testing and
5) Routine inspection, cleaning, maintenance,
calibration.
6) Actions to be taken in response to routine failure. 23
Reagents and
solutions
1) Reagents used in the operation should be specified in the SOPs.
2) Reagents and solutions should be labeled.
3) Deteriorated or outdated reagents and solutions should not be used.
4) Store under ambient temperature. 24
Animal
care
1) SOPs - for housing, feeding, handling and care of animals.
2) Animals should be free of any disease and if, during the course
of study, animals contract a disease then the diseased animals
shall be isolated.
3) Diagnosis, authorization of treatment, description and date of
treatment shall be documented and retained.
4) Animals of different species shall be housed in separated rooms
when necessary.
5) The animal cages, racks and accessory equipment shall be
cleaned and sanitized at appropriate intervals.
25
F
. Test and Control Articles
1) Test and control article characterization
2) Test and control article handling
3) Mixture of articles with carriers
26
Test and control article
characterization
1) The identity, strength, purity and composition or other
characteristics of test and control article shall be determined and
documented for each batch.
2) Methods of synthesis, fabrication or derivation shall be
documented by the sponsor or the testing facility.
3) Stability of each test and control article is determined.
4) Storage conditions are maintained and each storage container
shall be labeled by name, chemical abstract number or batch
number.
27
Test and control article
handling
Handling procedures of test and control articles ensures:
1) Proper storage.
2) Minimum risk of contamination and deterioration or damage.
batch
3) Receipt and distribution of each batch is documented.
4) Documentation include date and quantity of each
distributed or returned.
28
Mixture of articles with
carriers
1) Appropriate analytical methods shall be conducted for
determination of uniformity of mixture and concentration of test
or control article in mixture.
2) Stability of mixture is determined.
3) Expiration date should be written on the container.
29
G. Protocol for and conduct of
a nonclinical laboratory study
1) Protocol
2) Conduct of a nonclinical study
30
Protoco
l
Contents of protocol
1.Identification
2.Title and statement of purpose
3.Identification of test(or control) items
4.Names and address of the sponsor, test facility and test site
5.Name of the study director and other personnel
6.Proposed dates
7.Justification for selection of the test system
8.Description of the test system
9. Experimental design 31
Conduct of a nonclinical laboratory
study
1) Study shall be conducted in accordance with the protocol.
2) Information of the specimens should be present on the container
to avoid error in recording and storage of data.
3) All the data generated shall be recorded directly, promptly and
legibly by ink.
32
H. Records and
Reports
1) Reporting of nonclinical laboratory results
2) Storage, retrieval and retention of records and data
33
Reporting of nonclinical laboratory study
results
Final report shall contain:
1) Information on sponsor and test facility.
2) Experimental starting and completion dates.
3) Objectives and procedures stated in protocol(including the changes
in protocol).
4) Description of materials and test methods.
5) A Quality Assurance Programstatement.
34
6) Storage(specimens, reference items, raw data and final report).
Storage, retrieval and retention of
records and data
1) Archives should be there for orderly storage and expedient of all
raw data, documentation, protocols, specimens and final reports.
2) Index of materials retained.
3) Master schedule sheet, copies of protocols and records of
Quality Assurance inspections shall be maintained by QAU.
4) Wet specimens and samples of test and control articles shall be
retained until the quality of preparation affords evaluation.
5) If any study plan is disposed of before expiry the reason to be
justified and documented. 35
Conclusion
GLP is a FDA regulation which is accepted and approved a
s
international standards by OECD to avoid fraud activities of the
testing laboratories for pharmaceuticals to save human and
environmental health.
Gives better image of company as a Quality producer in global
market.
Also it establish good relationship among the countries.
36

More Related Content

PPTX
GOOD LABORATORY PRACTICES
PPTX
Good laboratory practices
PPTX
GOOD LABORATORY PRACTICES - A DETAILED STUDY
PPTX
Concept of glp
PDF
Good laboratory practices GLP
PPT
Good laboratory practices
PPTX
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
Good laboratory practices
GOOD LABORATORY PRACTICES - A DETAILED STUDY
Concept of glp
Good laboratory practices GLP
Good laboratory practices
GOOD LABORATORY PRACTICES

What's hot (20)

PPTX
Glp 112070804004
PPTX
COMPLAINTS. UNIT IV
PPTX
GLP - Good Laboratory Practices
PPTX
Quality review
PPTX
Purchase specifications & Maintenance of stores For Raw materials
PPTX
Good laboratory practices
PPTX
NABL ( NATIONAL ACCREDITATION BOARD DOR TESTING AND CALIBRATION LABORATORIES
PPTX
NABL ACCREDITATION
PPTX
calibration-and-validation
PPTX
2-Quality-assurance-6th-Sem Quality control and GMP
PPTX
Unit 4 Complaints.pptx
PPTX
NABL accreditation
PPTX
Good laboratory practices of pharmaceuticals
PPTX
QULITY ASSURANCE & QULITY MANAGEMENT CONCEPTS
PPTX
Documentation In Pharmaceutical Industry.pptx
PPTX
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
PPTX
GLP (Good Laboratory Practices)
PPTX
Quality control test: Containers, Closures and Secondary packing materials
PPTX
GMP.pptx
PPTX
Quality control test for packaging material ,qc test for glass,metal,rubber
Glp 112070804004
COMPLAINTS. UNIT IV
GLP - Good Laboratory Practices
Quality review
Purchase specifications & Maintenance of stores For Raw materials
Good laboratory practices
NABL ( NATIONAL ACCREDITATION BOARD DOR TESTING AND CALIBRATION LABORATORIES
NABL ACCREDITATION
calibration-and-validation
2-Quality-assurance-6th-Sem Quality control and GMP
Unit 4 Complaints.pptx
NABL accreditation
Good laboratory practices of pharmaceuticals
QULITY ASSURANCE & QULITY MANAGEMENT CONCEPTS
Documentation In Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
GLP (Good Laboratory Practices)
Quality control test: Containers, Closures and Secondary packing materials
GMP.pptx
Quality control test for packaging material ,qc test for glass,metal,rubber
Ad

Similar to good laboratory practice pdf (1).pdf (20)

PPTX
PPT ON GOOD LABORATORY PRACTICES (GLP)
PDF
pptonglp-161112173859.pdf
PPTX
PPT
Good laboratory practices (GLP) himanshu
PPT
Good Laboratory Practice(GLP) by Kashikant Yadav
PPTX
Good Laboratory Practices Pharmaceutical Quality Assurance
PPTX
OECD Principle of GLP (1).pptx
PPTX
GLP.pptx
PPTX
Good Laboratory Practices (GLP) Principles,.pptx
PPTX
Good laboratory practices
PPTX
Good Laboratory Practices Mubashir Maqbool
PPTX
Glp seminar
PPTX
Good Laboratory Practice (GLP). glp.pptx
PDF
Quality Assurance - Good Laboratory Practices .pdf
PPTX
Good Laboratory Practices in industries.
PDF
PDF
GLP in Pharmaceutical Industry by Dr.A S Charan
PPTX
Good laboratory practices.pptx M.PHARMACY
PPT ON GOOD LABORATORY PRACTICES (GLP)
pptonglp-161112173859.pdf
Good laboratory practices (GLP) himanshu
Good Laboratory Practice(GLP) by Kashikant Yadav
Good Laboratory Practices Pharmaceutical Quality Assurance
OECD Principle of GLP (1).pptx
GLP.pptx
Good Laboratory Practices (GLP) Principles,.pptx
Good laboratory practices
Good Laboratory Practices Mubashir Maqbool
Glp seminar
Good Laboratory Practice (GLP). glp.pptx
Quality Assurance - Good Laboratory Practices .pdf
Good Laboratory Practices in industries.
GLP in Pharmaceutical Industry by Dr.A S Charan
Good laboratory practices.pptx M.PHARMACY
Ad

More from Rajakumari Rajendran (20)

PPTX
microbial spoilage. Pharmaceutical microbial Spoilage
PPTX
microbial spoilage. Pharmaceutical microbial Spoilage
PPTX
CONCEPT-OF-GENERICS-GENERIC-DRUG-PRODUCT-DEVELOPMENT-1 (1).pptx
PPT
New drug discovery different stages development
PPTX
Drug Discovery with example stage 1 Process
PPTX
Morphology, Classification and Cultivation of Virus
PPTX
Intrinsic Dissolution Date from Elsevier
PPTX
Cultivation of Anaerobic Bacteria Microb
PPTX
Pharmaceutical Drug Development Process.
PPTX
Morphology and ,,Classification of Fungi
PPT
Pharma Specification WHO Quality Worksho
PPTX
Audit Management Pharmaceutical Presentation
PPTX
Quantitative measurement of bacterial growth.pptx
PPTX
microbial spoilage; Pharmaceutical Microbial Spoilage
PPTX
History of microbiology; Pharmaceutical Microbiology
PPTX
Pharmaceutical Degradation; Degradants in the Product
PPTX
Dissolution Official Test Monograph Pharma
PPTX
viralsafetyevaluationofbiotechnologyproductsderivedfrom-210804180136.pptx
PPTX
History of microbiology , History and the scientific contributions
PPTX
History of Microbiology, History, Microbiology
microbial spoilage. Pharmaceutical microbial Spoilage
microbial spoilage. Pharmaceutical microbial Spoilage
CONCEPT-OF-GENERICS-GENERIC-DRUG-PRODUCT-DEVELOPMENT-1 (1).pptx
New drug discovery different stages development
Drug Discovery with example stage 1 Process
Morphology, Classification and Cultivation of Virus
Intrinsic Dissolution Date from Elsevier
Cultivation of Anaerobic Bacteria Microb
Pharmaceutical Drug Development Process.
Morphology and ,,Classification of Fungi
Pharma Specification WHO Quality Worksho
Audit Management Pharmaceutical Presentation
Quantitative measurement of bacterial growth.pptx
microbial spoilage; Pharmaceutical Microbial Spoilage
History of microbiology; Pharmaceutical Microbiology
Pharmaceutical Degradation; Degradants in the Product
Dissolution Official Test Monograph Pharma
viralsafetyevaluationofbiotechnologyproductsderivedfrom-210804180136.pptx
History of microbiology , History and the scientific contributions
History of Microbiology, History, Microbiology

Recently uploaded (20)

PDF
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
PPTX
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PPTX
1. Drug Distribution System.pptt b pharmacy
PPTX
Bronchial_Asthma_in_acute_exacerbation_.pptx
PDF
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
PDF
2E-Learning-Together...PICS-PCISF con.pdf
PPTX
Nursing Care Aspects for High Risk newborn.pptx
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PDF
Structure Composition and Mechanical Properties of Australian O.pdf
PDF
Dr. Jasvant Modi - Passionate About Philanthropy
PPTX
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
PPTX
BLS, BCLS Module-A life saving procedure
PPT
Recent advances in Diagnosis of Autoimmune Disorders
PPTX
Trichuris trichiura infection
PPTX
First Aid and Basic Life Support Training.pptx
PPT
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
PPTX
Importance of Immediate Response (1).pptx
PPT
Adrenergic drugs (sympathomimetics ).ppt
PDF
MINERAL & VITAMIN CHARTS fggfdtujhfd.pdf
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
1. Drug Distribution System.pptt b pharmacy
Bronchial_Asthma_in_acute_exacerbation_.pptx
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
2E-Learning-Together...PICS-PCISF con.pdf
Nursing Care Aspects for High Risk newborn.pptx
Medical aspects of impairment including all the domains mentioned in ICF
Structure Composition and Mechanical Properties of Australian O.pdf
Dr. Jasvant Modi - Passionate About Philanthropy
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
BLS, BCLS Module-A life saving procedure
Recent advances in Diagnosis of Autoimmune Disorders
Trichuris trichiura infection
First Aid and Basic Life Support Training.pptx
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
Importance of Immediate Response (1).pptx
Adrenergic drugs (sympathomimetics ).ppt
MINERAL & VITAMIN CHARTS fggfdtujhfd.pdf

good laboratory practice pdf (1).pdf

  • 2.  In the early 70’s FDA became aware of cases of poor laboratory practice all over the United States.  They discovered a lot fraudulent activities and a lot of poor lab practices.  Examples of some of these poor lab practices found were : 1.Equipment not been calibrated to standard form , therefore giving wrong measurements. 2. Incorrect/inaccurate accounts of the actual lab study. 3. Inadequate test systems. GLP was first introduced in New Zealand and Denmark in 1972, and later in the US in 1978 in response to the Industrial Bio Test Labs scandal.
  • 4. Good Laboratory Practice (GLP)  GLP is a formal regulation created by USFDA as these regulations were proposed on November 19,1976 and designated as a new part of Chapter 21 of the Code of Federal Regulations(CFR) as 21 CFR Part 58 in 1979. organization named OECD(Organization for  In 1981 an Economic Cooperation and Development) produced GLP principles that are international standards.  GLP in OECD principles is defined as “a quality system concerned with the organizational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported”. 4
  • 5. Why GLP was created? 1) GLPs were initially invoked in a reaction to malpractices in the laboratories conducting safety experiments of medicines. 2) In the early 1970s,research laboratories in the USA found doing work in unethical ways ,like:  Data generation without conduct of the study.  Falsification of the laboratory work.  Replacement of dead animals and fabrication of test results etc. 5
  • 6. Advantages of GLP  Assures that the data are a true reflection of results obtained from studies.  Preclinical safety and residue safety.  Generation of high quality and reliable test data.  Mutual acceptance of data  Increases public confidence.  Shortens the time-to-market for new products. Disadvantages of GLP  More man power is required.  Expensive process.  Time consuming process. 6
  • 7. Objectives of GLP 1) GLP makes sure that the data submitted are true reflection of the results obtained from the studies. 2) GLP makes sure that the data is traceable. 3) Promotes international acceptance of tests. 7
  • 9. How to practice GLP? A. General provisions B. Organization and Personnel C. Facilities D. Equipment E. Testing facilities operation F. Test and control articles G. Protocol for and the conduct of the study H. Records and Reports 9
  • 10. A. General provisions 1) It prescribes GLP for conducting non-clinical laboratory studies that support research and marketing permits of products regulated by FDA. 2) Applicability to studies performed under grants and contracts. 3) Inspection of the testing facility. 10
  • 11. B. Organization and Personnel 1) Organization 2) Personnel 3) Testing facility management 4) Study director 5) Quality assurance unit 11
  • 12. Organization- Functions 1) Identification of quality activities. 2) Dividing the jobs among the personnel. of each job and 3) Define the authority and responsibility relationship of each job with other jobs. 4) Coordinate the work of internal departments and outside agencie1s0.
  • 13. Personne l Each individual engaged in the conduct or supervision of non- clinical laboratory study shall have: 1) Education 2) Training: a) General training b) Specific training 3) Experience or combination 4) Personal sanitation and health precautions 13
  • 14. Testing facility management 1) A sufficient number of qualified personnel, appropriate facilities, equipment and materials are available for conductance of the study. 2) Maintenance of records of qualifications, training and experience of personnel and their job description. 3) Appointment of study director. 4) Quality assurance program with designated personnel. 14
  • 15. Study Director A scientist or other professional of appropriate education , training and experience. Responsibilities of the study director are: 1) Approval of protocol and study plans including amendments. 2) Technical conduct of the study. 3) Ensure that the QA personnel and study personnel are updated with the study plan and SOPs. 4) Interpretation, analysis, documentation and reporting of the results. 5) Also checks that experimental data is accurately recorded and verified. 6) Sign and date the final report for acceptance of data. 15
  • 16. Quality Assurance Unit 1) An individual or a group designated by management to assure that the studies are in compliance with GLPprinciples. 2) Monitors the study to assure management that the facilities , equipment, personnel, methods, practices, records and controls are in conformance with the regulations. 3) Maintain the copies of master schedule sheet, protocol and SOPs. 4) Access to updated study plans and SOPs. 5) Documented verification of compliance of the study with GLP principles. 16
  • 17. Cont.… 5) Inspections to determine the compliance of the study with GLP principles and three type of inspections are: a) Study based inspections b) Process based inspections c) Facility based inspections 6) Determines any deviation from the approved protocol and report to SD,PI and management. 7) Prepare statements to be included in the final report containing dates and types of inspection. 17
  • 18. C. Facilities 1) General facilities: a) Testing system facilities b) Archive facilities c) Waste disposal 2) Animal care facilities 18
  • 19. General facilities a) Testing system facilities Suitable size, construction and location. Adequate degree of separation of different activities. Laboratories should be well ventilated, free of dust, drafts and extreme temperatures. Minimum 150sq.feet of floor space and minimum 6 linear feet of usable bench space should be provide for each analyst. b) Archive facilities- Secure storage and retrieval of study plans, raw data, final report and specimens to prevent untimely deterioration. c) Waste disposal- Appropriate collection, storage and disposal facilities and decontamination procedures. 19
  • 20. Animal care facilities 1) Located away form testing laboratories preferably in a separate building. 2) Contamination risk is reduced by “barrier” system ,as well as by providing “clean” and “dirty” corridors . 3) Separate areas for animals of different species and studies. 4) Separate areas for diagnosis, treatment and control of laboratory animal diseases. 5) Lightening should be proper as light intensity and noise level is sufficient. 6) Maintain room temperature, humidity and air changes in animal quarters. 20
  • 21. D. Equipment cleaned and 1) Appropriate design and adequate capacity. 2) Equipment shall be adequately inspected, maintained. 3) Equipment used for generation, measurement or assessment of data shall be adequately tested, calibrated and standardized. 4) Log books for each equipment should be there. 21
  • 22. E. Testing Facilities Operation 1) Standard operating procedures(SOPs) 2) Reagents and solutions 3) Animal care 22
  • 23. Standard Operating Procedures (SOPs)  reference items, apparatus, materials and reagents, record keeping, reporting, storage and retrieval, test systems and quality assurance procedures.  4) Any deviation from SOP should be authorized by SD and documented in the raw data. 1) Written documents specifying procedures for laboratories programs. 2) Testing facility should have a written SOP approved by management. 3) SOPs should be available wherever applicable e.g. test and testing and 5) Routine inspection, cleaning, maintenance, calibration. 6) Actions to be taken in response to routine failure. 23
  • 24. Reagents and solutions 1) Reagents used in the operation should be specified in the SOPs. 2) Reagents and solutions should be labeled. 3) Deteriorated or outdated reagents and solutions should not be used. 4) Store under ambient temperature. 24
  • 25. Animal care 1) SOPs - for housing, feeding, handling and care of animals. 2) Animals should be free of any disease and if, during the course of study, animals contract a disease then the diseased animals shall be isolated. 3) Diagnosis, authorization of treatment, description and date of treatment shall be documented and retained. 4) Animals of different species shall be housed in separated rooms when necessary. 5) The animal cages, racks and accessory equipment shall be cleaned and sanitized at appropriate intervals. 25
  • 26. F . Test and Control Articles 1) Test and control article characterization 2) Test and control article handling 3) Mixture of articles with carriers 26
  • 27. Test and control article characterization 1) The identity, strength, purity and composition or other characteristics of test and control article shall be determined and documented for each batch. 2) Methods of synthesis, fabrication or derivation shall be documented by the sponsor or the testing facility. 3) Stability of each test and control article is determined. 4) Storage conditions are maintained and each storage container shall be labeled by name, chemical abstract number or batch number. 27
  • 28. Test and control article handling Handling procedures of test and control articles ensures: 1) Proper storage. 2) Minimum risk of contamination and deterioration or damage. batch 3) Receipt and distribution of each batch is documented. 4) Documentation include date and quantity of each distributed or returned. 28
  • 29. Mixture of articles with carriers 1) Appropriate analytical methods shall be conducted for determination of uniformity of mixture and concentration of test or control article in mixture. 2) Stability of mixture is determined. 3) Expiration date should be written on the container. 29
  • 30. G. Protocol for and conduct of a nonclinical laboratory study 1) Protocol 2) Conduct of a nonclinical study 30
  • 31. Protoco l Contents of protocol 1.Identification 2.Title and statement of purpose 3.Identification of test(or control) items 4.Names and address of the sponsor, test facility and test site 5.Name of the study director and other personnel 6.Proposed dates 7.Justification for selection of the test system 8.Description of the test system 9. Experimental design 31
  • 32. Conduct of a nonclinical laboratory study 1) Study shall be conducted in accordance with the protocol. 2) Information of the specimens should be present on the container to avoid error in recording and storage of data. 3) All the data generated shall be recorded directly, promptly and legibly by ink. 32
  • 33. H. Records and Reports 1) Reporting of nonclinical laboratory results 2) Storage, retrieval and retention of records and data 33
  • 34. Reporting of nonclinical laboratory study results Final report shall contain: 1) Information on sponsor and test facility. 2) Experimental starting and completion dates. 3) Objectives and procedures stated in protocol(including the changes in protocol). 4) Description of materials and test methods. 5) A Quality Assurance Programstatement. 34 6) Storage(specimens, reference items, raw data and final report).
  • 35. Storage, retrieval and retention of records and data 1) Archives should be there for orderly storage and expedient of all raw data, documentation, protocols, specimens and final reports. 2) Index of materials retained. 3) Master schedule sheet, copies of protocols and records of Quality Assurance inspections shall be maintained by QAU. 4) Wet specimens and samples of test and control articles shall be retained until the quality of preparation affords evaluation. 5) If any study plan is disposed of before expiry the reason to be justified and documented. 35
  • 36. Conclusion GLP is a FDA regulation which is accepted and approved a s international standards by OECD to avoid fraud activities of the testing laboratories for pharmaceuticals to save human and environmental health. Gives better image of company as a Quality producer in global market. Also it establish good relationship among the countries. 36